123 related articles for article (PubMed ID: 9502330)
1. Folate and coronary heart disease.
Verhoef P; Stampfer MJ; Rimm EB
Curr Opin Lipidol; 1998 Feb; 9(1):17-22. PubMed ID: 9502330
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia and hyperlipidemia in coronary heart disease.
Gao W; Jiang N; Meng Z; Tang J
Chin Med J (Engl); 1999 Jul; 112(7):586-9. PubMed ID: 11601248
[TBL] [Abstract][Full Text] [Related]
3. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.
Klerk M; Verhoef P; Clarke R; Blom HJ; Kok FJ; Schouten EG;
JAMA; 2002 Oct 23-30; 288(16):2023-31. PubMed ID: 12387655
[TBL] [Abstract][Full Text] [Related]
4. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
[TBL] [Abstract][Full Text] [Related]
5. A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men.
Verhoef P; Rimm EB; Hunter DJ; Chen J; Willett WC; Kelsey K; Stampfer MJ
J Am Coll Cardiol; 1998 Aug; 32(2):353-9. PubMed ID: 9708460
[TBL] [Abstract][Full Text] [Related]
6. 5,10-Methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations are genetic determinants of elevated homocysteine.
Castro R; Rivera I; Ravasco P; Jakobs C; Blom HJ; Camilo ME; de Almeida IT
QJM; 2003 Apr; 96(4):297-303. PubMed ID: 12651974
[TBL] [Abstract][Full Text] [Related]
7. Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease?
Thuillier L; Chadefaux-Vekemans B; Bonnefont JP; Kara A; Aupetit J; Rochette C; Montalescot G; Couty MC; Kamoun P; Ankri A
J Inherit Metab Dis; 1998 Dec; 21(8):812-22. PubMed ID: 9870206
[TBL] [Abstract][Full Text] [Related]
8. Folate intake, serum folate, serum total homocysteine levels and methylenetetrahydrofolate reductase C677T polymorphism in young Japanese women.
Hiraoka M
J Nutr Sci Vitaminol (Tokyo); 2004 Aug; 50(4):238-45. PubMed ID: 15527064
[TBL] [Abstract][Full Text] [Related]
9. Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico.
Weinstein SJ; Gridley G; Harty LC; Diehl SR; Brown LM; Winn DM; Bravo-Otero E; Hayes RB
J Nutr; 2002 Apr; 132(4):762-7. PubMed ID: 11925474
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention.
Zhao M; Wang X; He M; Qin X; Tang G; Huo Y; Li J; Fu J; Huang X; Cheng X; Wang B; Hou FF; Sun N; Cai Y
Stroke; 2017 May; 48(5):1183-1190. PubMed ID: 28360116
[TBL] [Abstract][Full Text] [Related]
12. Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype.
Pullin CH; Ashfield-Watt PA; Burr ML; Clark ZE; Lewis MJ; Moat SJ; Newcombe RG; Powers HJ; Whiting JM; McDowell IF
J Am Coll Cardiol; 2001 Dec; 38(7):1799-805. PubMed ID: 11738277
[TBL] [Abstract][Full Text] [Related]
13. Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine.
Chiuve SE; Giovannucci EL; Hankinson SE; Hunter DJ; Stampfer MJ; Willett WC; Rimm EB
Am J Clin Nutr; 2005 Jul; 82(1):155-62. PubMed ID: 16002814
[TBL] [Abstract][Full Text] [Related]
14. [Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
Blankenberg S; Rupprecht HJ; Peetz D; Bickel C; Hofman KP; Tiret L; Meyer J
Dtsch Med Wochenschr; 2002 Apr; 127(14):729-35. PubMed ID: 11935469
[No Abstract] [Full Text] [Related]
15. Homocysteine and cardiovascular risk: the perils of reductionism in a complex system.
Ueland PM; Loscalzo J
Clin Chem; 2012 Dec; 58(12):1623-5. PubMed ID: 22623744
[No Abstract] [Full Text] [Related]
16. A common genetic variant affecting folate metabolism is not over-represented in chronic fatigue syndrome.
Harmon DL; McMaster D; McCluskey DR; Shields D; Whitehead AS
Ann Clin Biochem; 1997 Jul; 34 ( Pt 4)():427-9. PubMed ID: 9247678
[No Abstract] [Full Text] [Related]
17. Homocysteine and cardiovascular disease.
Scott J; Weir D
QJM; 1996 Aug; 89(8):561-3. PubMed ID: 8935476
[No Abstract] [Full Text] [Related]
18. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians.
Ma J; Stampfer MJ; Hennekens CH; Frosst P; Selhub J; Horsford J; Malinow MR; Willett WC; Rozen R
Circulation; 1996 Nov; 94(10):2410-6. PubMed ID: 8921781
[TBL] [Abstract][Full Text] [Related]
19. Severe methylenetetrahydrofolate reductase deficiency, methionine synthase, and nitrous oxide--a cautionary tale.
Erbe RW; Salis RJ
N Engl J Med; 2003 Jul; 349(1):5-6. PubMed ID: 12840086
[No Abstract] [Full Text] [Related]
20. Nutrigenetic impact of daily folate intake on plasma homocysteine and folate levels in patients with different methylenetetrahydrofolate reductase genotypes.
Messika AH; Kaluski DN; Lev E; Iakobishvili Z; Shohat M; Hasdai D; Mager A
Eur J Cardiovasc Prev Rehabil; 2010 Dec; 17(6):701-5. PubMed ID: 20421795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
